Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Hydroxyamine hydrochloride | HCID 443297 | — |
| Reactant | HCID 131730466 | HCID 131730466 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Solvent | Methanol--water (1/1) | HCID 22242641 | — |
| Product | HCID 68500325 | HCID 68500325 | 55.6% |
Reaction Steps
A solution of trans-methyl 4-(3-ethoxy-3-oxopropanoyl)-2-(4-(trifluoromethyl)benzyl)-piperidine-1-carboxylate (0.4 g, 0.96 mmol) in methanol (3 mL) was added dropwise to a solution of NaOH (0.042 g, 1.06 mmol) in methanol/water (3 mL/0.2 mL) at −30° C. After stirring for 10 min a solution of hydroxylamine hydrochloride (0.134 g, 1.93 mmol) and NaOH (0.077 g, 1.93 mmol) in methanol/water (5 mL/5 mL) was added at −30° C. Stirring was continued for 30 min at −30° C. The solution was added dropwise to 6 M HCl at 80° C. Stirred 30 min at 80° C. The reaction mixture was dissolved between water and ethyl acetate. The organic phase was isolated, dried with Na2SO4, filtered through celite and the solvent was evaporated. Acidic reversed phase chromatography, gradient 35% to 75% acetonitrile. Trans-methyl 4-(3-oxo-2,3-dihydroisoxazol-5-yl)-2-(4-(trifluoromethyl)benzyl)piperidine-1-carboxylate (205 mg, 55.4%) was isolated. 1H NMR (600 MHz, cdcl3) δ 1.63 (d, 2H), 1.98 (d, 2H), 2.81-3.14 (m, 4H), 3.55 (d, 3H), 4.21 (d, 1H), 4.63 (d, 1H), 5.63 (s, 1H), 7.22-7.37 (m, 2H), 7.54 (d, 2H). MS m/z 385 (M+H)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08415378B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-38d6a5b1176e4131b23c066504d93583 |
|---|
| Source note | uspto-grants-2013_04 |
|---|